Atrás
Precio Roivant Sciences Ltd (ROIV)
Gráfico del Precio de Acciones ROIV
ROIV Ganando
Roivant Sciences Ltd
$27.93
0.83%
$0.23
Al cierre: Mar 23, 16:00:00 GMT-4
$27.9
-0.1%
$-0.03
Mercado Posterior: Mar 23, 20:00:00 GMT-4
Estadísticas clave
Cierre Anterior
$27.7
Precio de apertura
$28.03
Rango del día
$27.66 - $28.39
Rango de 52 semanas
$8.73 - $30.33
Volumen
4.8M
Volumen promedio
6.2M
Rendimiento de dividendos
--
EPS (TTM)
-1.17
Cap. de mercado
$19.9B
¿Qué es ROIV?
Roivant Sciences Ltd. engages in the biopharmaceutical business, which engages in the development of transformative medicine. The Company’s pipeline includes brepocitinib, a potent small molecule inhibitor of TYK2 and JAK1 in development for the treatment of dermatomyositis, non-infectious uveitis and cutaneous sarcoidosis; IMVT-1402 and batoclimab, fully human monoclonal antibodies targeting FcRn in development across several IgG-mediated autoimmune indications; and mosliciguat, an inhaled sGC activator in development for pulmonary hypertension associated with interstitial lung disease. The company also incubates discovery-stage companies and health technology startups complementary to its biopharmaceutical business.
Características
© 2026 Finture Development Limited. Todos los derechos reservados.